3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Urge Urinary Incontinence: new trials by email Literature Review of Urge Urinary Incontinence trials Research Report on Urge Urinary Incontinence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE) Fesoterodine Fumarate - Urge Urinary Incontinence | Phase 3 | Completed | University of North Carolina, Chapel Hill | 61 | 2012-09-01 | 2020-03-18 |
| Anticholinergic vs. Botox Comparison Study Botulinum toxin A (Botox A®), Solifenacin 5mg, Solifenacin 10mg - Urge Urinary Incontinence, Overactive Bladder | Phase 3 | Completed | NICHD Pelvic Floor Disorders Network | 249 | 2010-03-01 | 2018-05-02 |
| Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence Oxybutynin, Placebo - Urge Urinary Incontinence, Urinary Frequency | Phase 3 | Completed | Antares Pharma Inc. | 626 | 2009-03-01 | 2014-07-02 |
Urinary Incontinence, Urge (3) · Urinary Bladder, Overactive (2)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Lower Urinary Tract Symptoms (3) · Male Urogenital Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Urinary Incontinence (3) · Urination Disorders (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Urological Manifestations (3) · Urinary Bladder Diseases (2)
Botulinum Toxins, Type A (1) · Solifenacin Succinate (1) · Tolterodine Tartrate (1) · fesoterodine (1) · oxybutynin (1) · trospium chloride (1)
Antares Pharma Inc. (1) · NICHD Pelvic Floor Disorders Network (1) · University of North Carolina, Chapel Hill (1)
United States (3)
Anthony Visco, MD (1) · Jennifer M Wu, MD (1)
PMID 22008247, PMID 23036134, PMID 26516810, PMID 27564385, PMID 33620895, PMID 38651909
R03AG042335 (1), U01HD041249 (1), U10HD041250 (1), U10HD041261 (1), U10HD041267 (1), U10HD054136 (1), U10HD054214 (1), U10HD054215 (1), U10HD054241 (1)